Santos, Isabel Fonseca <br/><br/>
Economic analysis of rivaroxaban for the treatment and long-term prevention of venous thromboembolism in Portugal.  [electronic resource] 

 -  Acta medica portuguesa   
 - 615-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1646-0758 
<br/><br/><label>Standard No.: </label>10.20344/amp.5257  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--therapeutic use<br/>Costs and Cost Analysis<br/>Enoxaparin--therapeutic use<br/>Factor Xa Inhibitors--economics<br/>Humans<br/>Models, Economic<br/>Portugal<br/>Quality-Adjusted Life Years<br/>Rivaroxaban--economics<br/>Time Factors<br/>Venous Thromboembolism--drug therapy<br/>Warfarin--therapeutic use